Oncology Institute (TOIIW) Accumulated Expenses (2019 - 2026)

Oncology Institute (TOIIW) has reported Accumulated Expenses for 8 consecutive years, with $24.3 million the latest figure, recorded in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $24.3 million, up 3.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.3 million (up 3.68% YoY), and the FY2025 annual result was $20.6 million, down 2.15% from the prior year.
• Accumulated Expenses was $24.3 million for Q1 2026 at Oncology Institute, up from $20.6 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $24.3 million in Q1 2026 and troughed at $12.2 million in Q1 2023.
• Average Accumulated Expenses over 5 years is $17.5 million, with a median of $16.1 million recorded in 2022.
• Year-over-year, Accumulated Expenses jumped 18045.0% in 2022 and decreased 21.21% in 2023.
• Over 5 years, Accumulated Expenses stood at $14.6 million in 2022, then retreated by 4.1% to $14.0 million in 2023, then surged by 50.71% to $21.1 million in 2024, then dropped by 2.15% to $20.6 million in 2025, then increased by 17.72% to $24.3 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $24.3 million in Q1 2026, $20.6 million in Q4 2025, and $22.8 million in Q3 2025.